Bone Biologics Corporation BBLG
0.35 USD +0.01 (+2.58%)
At closeNov 11, 2026, 4:00 PM EST
0.36 +0.01 +3.60%
After hours · Nov 11, 4:00 PM ET
0.3398 Day range 0.3752
0.315 52-week range 2.39
- YTD
- -75.86%
- 1 year
- -79.77%
News
benzinga.com Bone Biologics Q3 EPS $(0.17) Beats $(0.18) Estimate Bone Biologics (NASDAQ:BBLG) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.18) by 5.56 percent. This is a 54.05 percent increase over losses of…
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Biodexa Pharmaceuticals (NASDAQ:BDRX) stock rose 13.3% to $0.55 during Wednesday's after-market session. Impact BioMedical (AMEX:IBO) stock rose 10.77% to $3.77. The company's market cap…
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers GlucoTrack (NASDAQ:GCTK) stock moved upwards by 90.6% to $3.87 during Wednesday's after-market session. The market value of their outstanding shares is at $1.7 million. Greenland Mines…
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session Gainers Aethlon Medical (NASDAQ:AEMD) shares increased by 382.5% to $6.9 during Thursday's pre-market session. The company's market cap stands at $1.0 million. Akanda (NASDAQ:AKAN) stock rose 15.07%…
defenseworld.net Short Interest in Bone Biologics Corp. (NASDAQ:BBLG) Drops By 76.4% Bone Biologics Corp. (NASDAQ: BBLG - Get Free Report) was the target of a large decrease in short interest in August. As of August 31st, there was short interest totaling 36,999 shares, a decrease of…
globenewswire.com Bone Biologics Expands Trial Sites BURLINGTON, MA, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation (Nasdaq: BBLG, BBLGW) (“Bone Biologics” or the “Company”), a developer of orthobiologic products for spine fusion…
globenewswire.com Bone Biologics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference BURLINGTON, MA, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion…- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Veeva Systems (NYSE:VEEV) shares increased by 8.7% to $266.15 during Wednesday's after-market session. The market value of their outstanding shares is at $40.0 billion. The company's, Q2…
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers ENvue Medical (NASDAQ:FEED) shares rose 49.1% to $0.61 during Wednesday's after-market session. The market value of their outstanding shares is at $2.4 million. Omeros (NASDAQ:OMER) stock…- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers BioVie (NASDAQ:BIVI) shares increased by 39.4% to $1.77 during Wednesday's regular session. The market value of their outstanding shares is at $9.5 million. Sionna Therapeutics (NASDAQ:SION)…
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Bone Biologics (NASDAQ:BBLG) stock moved upwards by 17.7% to $1.07 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.6 million. Definium Therapeutics
globenewswire.com Bone Biologics Achieves 32-Month Validated Shelf Life for rhNELL-1 BURLINGTON, Mass, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion…
defenseworld.net Bone Biologics (BBLG) to Announce Earnings on Thursday Bone Biologics (NASDAQ: BBLG - Get Free Report) will likely be issuing its results before the market opens on Thursday, August 13th. Analysts expect Bone Biologics to announce earnings of ($0.39) per…
globenewswire.com Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities BURLINGTON, Mass, July 23, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation (Nasdaq: BBLG, BBLGW) ("Bone Biologics" or the "Company"), a developer of orthobiologic products for spine fusion…- benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers AVITA Medical (NASDAQ:RCEL) stock moved upwards by 11.1% to $4.9 during Thursday's after-market session. The market value of their outstanding shares is at $143.1 million. Lisata Therapeutics…
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers Catheter Precision (AMEX:VTAK) shares moved upwards by 95.7% to $1.4 during Wednesday's regular session. The market value of their outstanding shares is at $2.5 million. Tvardi Therapeutics…
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Catheter Precision (AMEX:VTAK) shares moved upwards by 55.8% to $1.11 during Wednesday's pre-market session. The company's market cap stands at $2.5 million. Innovative Eyewear (NASDAQ:LUCY)…
benzinga.com Why iOThree Shares Are Trading Higher By Around 70%; Here Are 20 Stocks Moving Premarket iOThree Ltd (IOTR) rose in premarket trading after strong fiscal 2026 results. Gainers include EDBL, DCX, WFF, TC, SHPH, BATL, KC, VEEE, BABA.
globenewswire.com Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules $3.0 million upfront with up to approximately $6.0 million of potential additional gross proceeds upon the exercise in full of warrants in cash $3.0 million upfront with up to approximately $6.0…
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers Catheter Precision (AMEX:VTAK) shares rose 78.2% to $1.55 during Monday's after-market session. The company's market cap stands at $2.2 million. Allarity Therapeutics (NASDAQ:ALLR) stock…
benzinga.com Why Marvell Technology Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket href=https://www.benzinga.com/quote/RMSG target=_blank>(NASDAQ: RMSG) lost 67.6% to $0.69 in pre-market trading. The company recently announced a 1-for-20 reverse stock split.The shares of Marvell…- benzinga.com Bone Biologics Announces Validated Shelf Life Extension Of Its rhNELL-1 Protein Product To 29 Months The updated shelf life is supported by continued third-party stability data. The additional five months of validated product life is expected to provide greater flexibility in lot sizing and…
benzinga.com Bone Biologics Q1 EPS $(0.43) Beats $(0.54) Estimate Bone Biologics (NASDAQ:BBLG) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of $(0.54) by 20.37 percent. This is a 77.6 percent increase over losses of…
benzinga.com Watching Bone Biologics; Zacks Small-Cap Research Gives Stock $22.20/Share Price Valuation https://s27.q4cdn.com/906368049/files/News/2026/Zacks_SCR_Research_03032026_BBLG_Sorensen.pdf- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
globenewswire.com Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook Key accomplishments include expanded rhNELL-1 shelf life, advanced NB1 development, strengthened balance sheet, and maintained Nasdaq compliance Key accomplishments include expanded rhNELL-1 shelf…- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com Bone Biologics Extends Shelf Life Of rhNELL‑1 To 24 Months, Meeting Forecasts Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ:BBLG, BBLGW))), a developer of orthobiologic products for spine fusion markets, announces it has received confirmation that the…
globenewswire.com Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months Milestone advances manufacturing readiness and supports long-term commercialization strategy Milestone advances manufacturing readiness and supports long-term commercialization strategy
defenseworld.net Bone Biologics (NASDAQ:BBLG) Shares Down 0.5% – Should You Sell? Bone Biologics Corp. (NASDAQ: BBLG - Get Free Report)'s share price fell 0.5% during trading on Wednesday. The stock traded as low as $1.9246 and last traded at $2.10. 43,801 shares were traded…- benzinga.com Watching Bone Biologics; Zacks Small-Cap Research Gives Stock $22.25 Price Valuation https://s27.q4cdn.com/906368049/files/News/2025/Zacks_SCR_Research_11172025_BBLG_Sorensen.pdf
- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session 
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session 
businesswire.com Bone Biologics CEO Issues Letter to Stockholders Highlighting Company Update and Outlook BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, announces…- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
businesswire.com Bone Biologics Announces Closing of $5.0 Million Public Offering BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today…
benzinga.com Why Venus Concept Shares Are Trading Higher By Over 32%; Here Are 20 Stocks Moving Premarket 
benzinga.com Why Is Bone Biologics Stock Surging On Friday? Bone Biologics Corporation BBLG stock is trading higher on Friday, with a session volume of 17.22 million compared to the average volume of 38.795K as per data from Benzinga Pro.
businesswire.com Bone Biologics Announces Pricing of $5.0 Million Public Offering BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today…
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session 
businesswire.com Bone Biologics Files Patent Application for Bone Regeneration Technology BURLINGTON, Mass.--(BUSINESS WIRE)---- $BBLG #Bonebiologics--Bone Biologics files U.S. patent application for bone regeneration technology.
businesswire.com Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today…- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
businesswire.com Bone Biologics Announces 1-for-6 Reverse Stock Split BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today…- benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session 
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session